1 Min Read
Oct 13 (Reuters) - Janssen-Cilag International NV:
* CHMP issues a positive opinion on Janssen’s Zytiga to include earlier stage prostate cancer patients Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.